Sex-Specific Immune Cell Variations Influence Obesity-Related Metabolic Risks
Researchers have identified sex-specific immune cell variations in fat tissue that influence metabolic health, suggesting that future obesity treatments may…

Recent research identifies distinct variations in immune cell behavior within adipose tissue that correlate with biological sex, offering a potential explanation for disparate metabolic responses to obesity. The study highlights the role of eosinophils—immune cells traditionally associated with allergic responses—which exhibit diverse functional profiles depending on the host's sex.
High-resolution single-cell sequencing revealed six distinct populations of eosinophils in fat tissue, each possessing unique gene expression patterns. In female subjects, specific eosinophil populations appear to facilitate protective communication with macrophages, promoting metabolic stability. Conversely, male subjects demonstrated a higher prevalence of inflammatory eosinophil populations when exposed to high-fat diets, suggesting a reduced capacity for protective immune regulation.
The research identifies the protein RELM alpha as The research identifies the protein RELM alpha as a critical mediator in the communication between eosinophils and macrophages. This protein appears to stabilize beneficial immune interactions, particularly in female subjects, thereby mitigating inflammation. These findings suggest that the metabolic impact of obesity is not solely determined by the quantity of immune cells present, but by their functional characteristics and inter-cellular signaling pathways.
While these findings provide a framework for understanding sex-based differences in metabolic health, the data is currently limited to murine models. Although human adipose tissue has been shown to contain similar eosinophil populations, the specific functions of these cells in human physiology remain unverified. Future clinical development of obesity therapeutics will likely require sex-specific strategies, as immune-targeted interventions may produce divergent outcomes based on the patient's biological sex. Further research is required to determine if these pathways can be safely modulated in human clinical settings.
More stories
- Dietitians advise small swaps for plant-based eating
- TikTok dementia videos mislead in 66.4% of sample, researchers say
- Aberdeen Royal Infirmary faces police inquiry call over 19 deaths
- Bariatric surgery group loses 28.2% after GLP-1 use
- TOFA boosts mouse energy use 18% while preserving muscle
- ICO probes NHS therapy notes accessible to up to 140,000 staff
- Europe faces 35,000 drug-resistance deaths a year
- U.S. faces loss of measles elimination status after 5,412 cases
- Vanillin shows wound-care potential in early research
- Menin restoration improves older-mouse memory in 30 days
Latest news
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence
- Baltic responders fight Sparta II fire after drone strike
- Europe faces attribution gap after 16 cyber, physical incidents

